Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CMR Surgical Submits Versius Plus to FDA for Gynecology
OEM News

CMR Surgical Submits Versius Plus Surgical Robot to FDA for Gynecology

The robotic surgical system seeks FDA clearance for total hysterectomy as well as oophorectomy, salpingectomy, and other gynecologic procedures.

The Versius surgical robotic System. Photo: CMR Surgical

CMR Surgical announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its Versius Plus surgical robotic system.

The submission seeks clearance to market the device for benign gynecology procedures like total hysterectomy as well as oophorectomy, salpingectomy, and other gynecologic procedures.

According to the company, Versius is the second most used surgical robotic system globally outside of the U.S., with rising adoption across multiple specialties. To date, gynecologic procedures represent a large proportion of all Versius cases recorded across the world.

Versius plus is an adaptable and versatile modular system. It gives surgeons the flexibility to use familiar laparoscopic port placement with the precision of fully wristed instrumentation compatible with 5 mm ports, and advanced 3D visualization on a digitally integrated platform.

“It is an exciting time for CMR as we seek to expand into gynecology in the U.S. and accelerate access to robotic-assisted surgery with Versius Plus in the largest surgical robotic market in the world,” said Massimiliano Colella, CEO of CMR Surgical. “We already have extensive global experience across gynecology and other specialties, and this submission reflects our commitment to bringing a versatile, surgeon-centric solution to more hospitals and healthcare systems in the United States.”

This announcement follows CMR’s achievement of over 45,000 patients being treated around the world using the company’s Versius system.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics